Today, digital technologies measuring biometrics have become commonplace, from tracking daily step counts and heart rates during morning jogs to analysing nightly deep sleep duration. Can these technologies also be leveraged to provide reliable information in dementia research and care?

This key question, among many others, was addressed in a CURE-ND panel discussion during the Brain Innovation Days – an initiative from the European Brain Council – on 13-14 November 2024 in Brussels.

The panel consisted of:

• Valerie Godefroy, FrontLab team (ICM / Paris Brain Institute, France)
• Prof Dr Maarten Van Den Bossche (Mission Lucidity, KU/UZ Leuven, Belgium)
• Sarah Daniels, Consultant Therapist, Health and Social Care Lead (UK Dementia Research Institute - Care Research and Technology Centre, Imperial College London)
• Prof Dr Emrah Duezel, Research Group Leader, Clinical Neurophysiology and Memory (DZNE); CSO and co-founder spin-off Neotiv
• Jurn Verschraegen, Director Flemish Expert Centre on Dementia Care

They explored the transformative potential of digital technology, particularly sensing devices and wearable biometrics, in enhancing dementia care and personalizing interventions. Some of the focus points were how digital technology and biomarkers such as wearable-derived measures can revolutionize dementia care by providing continuous, real-time monitoring of biometrics, enabling early detection of cognitive decline and behavioural changes, and facilitating tailored interventions. The panel also touched upon the challenges and hurdles that still need to be addressed to implement these digital technologies in clinical practice and home therapy contexts.

By convening international experts from diverse fields, the panel aimed to inspire all involved parties and start future discussions towards successful implementation of digital technology in transforming dementia care, ultimately improving outcomes for patients and caregivers alike.